Patents by Inventor James Galen

James Galen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9050283
    Abstract: The present invention is drawn to attenuated Salmonella serovar strains S. Typhimurium and S. Enteritidis, conjugate vaccines derived from these attenuated strains of S. Typhimurium and S. Enteritidis, comprising an O polysaccharide covalently linked to a flagellin protein, and methods for inducing an immune response in a subject comprising administering the attenuated strains and/or the conjugate vaccines of the invention.
    Type: Grant
    Filed: January 16, 2010
    Date of Patent: June 9, 2015
    Assignee: University of Maryland, Baltimore
    Inventors: Myron M. Levine, Raphael Simon, James Galen, Sharon Tennant
  • Patent number: 8137930
    Abstract: The present invention is drawn to a live, attenuated S. Paratyphi A strain, a live, attenuated S. Paratyphi A strain comprising a stabilized plasmid expression system, an S. Paratyphi conjugate vaccine, and methods of using these strains and conjugate vaccine.
    Type: Grant
    Filed: March 6, 2009
    Date of Patent: March 20, 2012
    Assignee: University of Maryland, Baltimore
    Inventors: Christofer Vindurampulle, Eileen M. Barry, Myron M. Levine, James Galen
  • Publication number: 20120029173
    Abstract: The present invention is drawn to a live, attenuated S. Paratyphi A strain, a live, attenuated S. Paratyphi A strain comprising a stabilized plasmid expression system, an S. Paratyphi conjugate vaccine, and methods of using these strains and conjugate vaccine.
    Type: Application
    Filed: March 6, 2009
    Publication date: February 2, 2012
    Applicant: University of Maryland, Baltimore
    Inventors: Christofer Vindurampulle, Eileen M. Barry, Myron M. Levine, James Galen
  • Publication number: 20110274714
    Abstract: The present invention is drawn to attenuated Salmonella serovar strains S. Typhimurium and S. Enteritidis, conjugate vaccines derived from these attenuated strains of S. Typhimurium and S. Enteritidis, comprising an O polysaccharide covalently linked to a flagellin protein, and methods for inducing an immune response in a subject comprising administering the attenuated strains and/or the conjugate vaccines of the invention.
    Type: Application
    Filed: January 16, 2010
    Publication date: November 10, 2011
    Applicant: University of Maryland, Baltimore
    Inventors: Myron M. Levine, Raphael Simon, James Galen, Sharon Tennant
  • Publication number: 20070281348
    Abstract: The present invention relates generally to a Plasmid Maintenance System for the stabilization of expression plasmids encoding foreign antigens, and methods for making and using the Plasmid Maintenance System. The invention optimizes the maintenance of expression plasmids at two independent levels by: (1) removing sole dependence on balanced lethal maintenance functions; and (2) incorporating at least one plasmid partition function to prevent random segregation of expression plasmids, thereby enhancing their inheritance and stability. The Plasmid Maintenance System may be employed within a plasmid which has been recombinantly engineered to express a variety of expression products.
    Type: Application
    Filed: October 4, 2006
    Publication date: December 6, 2007
    Inventors: James Galen, Christofer Vindurampulle
  • Publication number: 20060147461
    Abstract: The disclosure below provides a protein export system for efficiently producing recombinant protein from a host cell. In a preferred embodiment, the protein export system utilizes protein export machinery endogenous to the host bacterium into which the protein export system vector is introduced.
    Type: Application
    Filed: December 12, 2005
    Publication date: July 6, 2006
    Inventor: James Galen
  • Publication number: 20060030048
    Abstract: The present invention relates generally to a Plasmid Maintenance System for the stabilization of expression plasmids encoding foreign antigens, and methods for making and using the Plasmid Maintenance System. The invention optimizes the maintenance of expression plasmids at two independent levels by: (1) removing sole dependence on balanced lethal maintenance functions; and (2) incorporating at least one plasmid partition function to prevent random segregation of expression plasmids, thereby enhancing their inheritance and stability. The Plasmid Maintenance System may be employed within a plasmid which has been recombinantly engineered to express a variety of expression products.
    Type: Application
    Filed: September 19, 2005
    Publication date: February 9, 2006
    Inventor: James Galen
  • Publication number: 20060030047
    Abstract: The present invention relates generally to a Plasmid Maintenance System for the stabilization of expression plasmids encoding foreign antigens, and methods for making and using the Plasmid Maintenance System. The invention optimizes the maintenance of expression plasmids at two independent levels by: (1) removing sole dependence on balanced lethal maintenance functions; and (2) incorporating at least one plasmid partition function to prevent random segregation of expression plasmids, thereby enhancing their inheritance and stability. The Plasmid Maintenance System may be employed within a plasmid which has been recombinantly engineered to express a variety of expression products.
    Type: Application
    Filed: September 19, 2005
    Publication date: February 9, 2006
    Inventor: James Galen
  • Publication number: 20060029616
    Abstract: The present invention relates generally to a Plasmid Maintenance System for the stabilization of expression plasmids encoding foreign antigens, and methods for making and using the Plasmid Maintenance System. The invention optimizes the maintenance of expression plasmids at two independent levels by: (1) removing sole dependence on balanced lethal maintenance functions; and (2) incorporating at least one plasmid partition function to prevent random segregation of expression plasmids, thereby enhancing their inheritance and stability. The Plasmid Maintenance System may be employed within a plasmid which has been recombinantly engineered to express a variety of expression products.
    Type: Application
    Filed: September 19, 2005
    Publication date: February 9, 2006
    Inventor: James Galen
  • Publication number: 20050003539
    Abstract: The present invention relates generally to a Plasmid Maintenance System for the stabilization of expression plasmids encoding foreign antigens, and methods for making and using the Plasmid Maintenance System. The invention optimizes the maintenance of expression plasmids at two independent levels by: (1) removing sole dependence on balanced lethal maintenance functions; and (2) incorporating at least one plasmid partition function to prevent random segregation of expression plasmids, thereby enhancing their inheritance and stability. The Plasmid Maintenance System may be employed within a plasmid which has been recombinantly engineered to express a variety of expression products.
    Type: Application
    Filed: January 5, 2004
    Publication date: January 6, 2005
    Inventor: James Galen